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T-cell receptor ligation by peptide/MHC induces
activation of a caspase in immature thymocytes:
the molecular basis of negative selection
generally involves thymocytes at the DP stage ofLinda K.Clayton1,3,7, Yoseph Ghendler1,3,
development.Emiko Mizoguchi2,4, Raymond J.Patch5,
Although the mechanism of negative selection isTimothy D.Ocain5, Kim Orth6,
unknown, the targeted thymocytes die via apoptosisAtul K.Bhan2,4, Vishva M.Dixit6 and
(Murphy et al., 1990), a physiologically controlled form
Ellis L.Reinherz1,3
of cell death utilized by metazoan organisms during normal
development as well as for homeostasis (Vaux, 1993;1Laboratory of Immunobiology, Dana-Farber Cancer Institute,
Steller, 1995; Vaux and Strasser, 1996). Apoptosis occurs2Department of Pathology, Massachusetts General Hospital,
Departments of 3Medicine and 4Pathology, Harvard Medical School, as a consequence of extracellular signaling events such as
Boston, MA 02115, 5Department of Medicinal Chemistry, crosslinking of certain receptors including CD95 (Trauth
Procept, Inc., 840 Memorial Drive, Cambridge, MA 02139 and et al., 1989; Yonehara et al., 1989; Itoh and Nagata, 1993;6Department of Pathology, University of Michigan Medical School,
Alderson et al., 1994; Takahashi et al., 1994), TNFAnn Arbor, MI 48109, USA
receptors (Tartaglia et al., 1993) and a recently identified7Corresponding author
Death Receptor 3 (DR3) (Chinnaiyan et al., 1996a) or as
a result of growth factor withdrawal (reviewed in Yang
T-cell receptors (TCRs) are created by a stochastic gene
and Korsmeyer, 1996). Upon induction of apoptosis,
rearrangement process during thymocyte development,
cells undergo a morphologically characteristic process of
generating thymocytes bearing useful, as well as
nuclear condensation, blebbing of cellular membranes and
unwanted, specificities. Within the latter group, auto- disintegration into small fragments which are removed by
reactive thymocytes arise which are subsequently phagocytes (Vaux, 1993; Vaux and Strasser, 1996; for
eliminated via a thymocyte-specific apoptotic mechan- review see Steller, 1995).
ism, termed negative selection. The molecular basis of Recent analyses of the death pathways in various
this deletion is unknown. Here, we show that TCR systems have begun to delineate the biochemical basis of
triggering by peptide/MHC ligands activates a caspase apoptosis. Particularly, activation of ICE-like cysteine
in double-positive (DP) CD4CD8 thymocytes, proteases now termed caspases has proven to be a hallmark
resulting in their death. Inhibition of this enzymatic of apoptotic death (reviewed in Nalin, 1995; Henkart,
activity prevents antigen-induced death of DP thymo- 1996). There are presently 10 human homologues of the
cytes in fetal thymic organ culture (FTOC) from TCR ced 3 cysteine protease first defined by genetic analysis
transgenic mice as well as apoptosis induced by anti- of cell death in Caenorhabditis elegans (Alnemri et al.,
CD3ε monoclonal antibody and corticosteroids in 1996; Duan et al., 1996a; Fernandes-Alnemri et al., 1996;
FTOC of normal C57BL/6 mice. Hence, a common Muzio et al., 1996; reviewed in Henkart, 1996). These
caspase mediates immature thymocyte susceptibility to enzymes exist as inactive proenzymes which become
cell death. active when cleaved to subunits of ~17–20 kDa and ~10–
Keywords: apoptosis/caspase/negative selection/thymus 12 kDa. The molecular structures of ICE (caspase-1) and
Yama (caspase-3) have been determined (Walker et al.,
1994; Wilson et al., 1994; Rotonda et al., 1996). The
active enzymes exist as tetramers made up of two large
and two small subunits. Comparison of these structuresIntroduction
suggests that the caspase family falls into two major
The T-cell repertoire is generated through a tightly regu- groups: those that most resemble caspase-1 and those that
lated developmental program of selection or ‘filtering’ most resemble caspase-3 (and also ced-3). The substrate
in which thymocytes bearing immunologically desirable binding pockets of these two groups have distinct differ-
T-cell receptor (TCR) specificities are preserved and those ences pointing to potentially unique substrate specificities.
expressing harmful specificities are eliminated (reviewed The active sites contain a critical cysteine within the
in Fowlkes and Pardoll, 1989). T-lineage cells expressing canonical pentapeptide, QACR/QG, and R and Q residues
autoreactive TCRs are deleted in the thymus via a process (Arg179, Gln283 and Arg341 for example in caspase-3)
termed negative selection (reviewed in Nossal, 1994). conserved among all caspase family members. A unique
Multiple lines of evidence utilizing both normal and characteristic of these enzymes is that they cleave after
transgenic mice show that this negative selection process an aspartic acid residue in their substrate (Sleath et al.,
occurs during a restricted stage(s) of thymic differentiation 1990; Howard et al., 1991; Thornberry et al., 1994). Thus,
(Fowlkes et al., 1988; Kisielow et al., 1988; Fowlkes and the fact that activation of these enzymes occurs by cleavage
Pardoll, 1989; Murphy et al., 1990; Vasquez et al., 1992; at aspartic acid residues suggests both autocatalytic cap-
Sebzda et al., 1994). The deletion process requires TCR abilities and the possibility of a cascade of various cysteine
recognition of antigenic peptides displayed on APCs in proteases with one family member activating others during
apoptosis.complex with MHC class I or class II molecules and
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To date, the characterization of caspase enzymatic
activities has typically been investigated using transfected
cell lines. Hence, the physiological roles of most of these
various cysteine proteases in vivo are at present unclear.
Three cysteine proteases, caspase-3, Mch2 (caspase-6)
and ICE-LAP3 (caspase-7), have been shown to be proteo-
lytically activated by apoptotic stimuli, implying a central
role for this family of enzymes in cell death in vivo
(Chinnaiyan et al., 1996b; Duan et al., 1996b; Orth et al.,
1996a; Schlegel et al., 1996). Given that apoptosis is
linked to negative selection in the thymus, we herein
examine the potential role of caspase activity in antigen-
triggered deletion of CD4CD8 double-positive (DP)
fetal and adult thymocytes. Using peptide-based enzyme
substrates we show that TCR ligation by peptide/MHC
activates a procaspase in DP thymocytes which then
causes cell death; specific enzyme inhibitors block this
death process. These findings provide the molecular basis
for negative selection.
Results
Caspases are irreversibly inhibited by tri- or tetrapeptide
sequences (VAD, YVAD and/or DEVD) linked to a
chemical moiety such as fluoromethyl ketone (fmk) or
various acyloxymethyl ketones (amk) which covalently
modify the enzyme, thereby inactivating its catalytic
function (Chapman, 1992; Thornberry et al., 1992, 1994;
Rotonda et al., 1996). The peptide-based inhibitor,
N -benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethyl
ketone (zVADfmk), blocks the induction of apoptosis
induced by expression of REAPER protein when added Fig. 1. A caspase inhibitor blocks deletion of DP thymocytes induced
by anti-CD3ε mAb and glucocorticoids. (A) FACS analysis isto Drosophila Schneider cells (Pronk et al., 1996); such
presented for FTOC from C57BL/6 mice following 18 h of treatmentexperiments demonstrate that REAPER-induced apoptosis
with: (a) no addition; (b) 200 μg/ml 145-2C11 mAb; (c) 100 μm
requires activation of a caspase. zVADfmk; (d) 2 h treatment with 100 μm zVADfmk followed by 18 h
In order to analyze the effect of inhibition of members with 200 μg/ml 145-2C11 mAb; (e) 2 h treatment with 0.25% DMSO
followed by 18 h with 200 μg/ml 145-2C11 mAb. (B) FACS analysisof the caspase family of cysteine proteases on negative
following 18 h of treatment with: (a) no addition; (b) 0.1 μMselection in the thymus, we have utilized a fetal thymic
dexamethasone; (c) 2 h with 100 μM zVADfmk followed by 18 h withorgan culture (FTOC) system. FTOC was chosen over
0.1 μM dexamethasone; (d) 2 h pretreatment with 0.25% DMSO
either in vivo whole-animal studies or in vitro cell suspen- followed by 18 h with 0.1 μM dexamethasone. Fetal lobes (three to
sion cultures for several reasons. First, FTOC allows five per group) were cultured for 4 days, treated as indicated and
harvested on day 5. Lobes were dissociated and thymocytes stainedanalysis of the effects of pharmaceutical agents on thymo-
with directly conjugated anti-CD8-Red613 and anti-CD4-PE. 10 000cyte development in a system which more closely mimics
cells were analyzed per dot plot. The numbers within the quadrantsin vivo conditions than does thymocyte suspension culture. represent the percent of cells in that quadrant.
Second, pharmacophores which cannot be utilized in
whole mice either due to systemic toxicity or limitations
in their bioavailability can be assayed easily in FTOC. of 100 μM zVADfmk, an irreversible inhibitor of cysteine
proteases, and thymocytes harvested 18 h later. Figure 1AFurthermore, the relatively small volumes required
minimize the amount of chemical required. shows the FACS analysis of C57BL/6 fetal thymuses after
such a treatment. Upon 2C11 mAb addition, the percent
of DP thymocytes is reduced from 66% in the controlCaspase inhibition in FTOC prevents DP thymocyte
deletion mediated by anti-CD3ε mAb culture to 37% in the culture treated for 18 h with
200 μg/ml 2C11 mAb (Figure 1A, compare panels a andPrior studies utilizing the anti-CD3ε-specific hamster anti-
mouse mAb 145-2C11 (2C11) have shown that DP thymo- b). Moreover, the deletion of these DP thymocytes is
inhibited by a 2 h preincubation with zVADfmk (Figurecytes are susceptible to undergo apoptotic cell death upon
exposure to 2C11 in FTOC (Smith et al., 1989) or upon 1A, panel d). Note that zVADfmk alone does not alter the
percentage of DP thymocytes (Figure 1A, panel c) norparenteral in vivo administration (Shi et al., 1991). We
therefore first analyzed the effect of a caspase inhibitor does dimethyl sulfoxide (DMSO), the additive used to
solubilize zVADfmk, affect the deletion of DP thymocyteson anti-CD3ε-induced deletion of the CD4CD8 DP
thymocytes using C57BL/6 animals. Fetal thymocytes (Figure 1A, panel e). A control hamster anti-mouse mAb,
H28 (Becker et al., 1989), directed against a segment ofwere dissected on day 14.5 of pregnancy and cultured in
transwells for 4 days. On day 4, additions were made to the TCR α chain which is inaccessible on intact thymo-
cytes, has no effect on the FTOC (data not shown).the FTOCs including 2C11 mAb in the presence or absence
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zVADfmk inhibits glucocorticoid-induced DP
thymocyte death in FTOC
DP thymocytes are exquisitely sensitive to pharmaco-
logical doses of glucocorticoids in vivo (Wyllie et al.,
1980). The rapid thymic involution known to result from
stress is a consequence, in large part, also of endogenous
release of steroids. To determine whether caspase inhibi-
tion blocks DP thymocyte apoptosis induced by cortico-
steroids, the effects of dexamethasone on DP thymocyte
survival in FTOC were examined in the presence or
absence of zVADfmk. As shown in Figure 1B, dexametha-
sone at 0.1 μM reduces the percentage of DP thymocytes
from 74% to 19% (Figure 1B, compare panels a and b).
A 2 h pretreatment with 100 μM zVADfmk protects
the CD4CD8 population from dexamethasone-induced
death (Figure 1B, panel c). The inhibition of deletion is
specific to the zVADfmk reagent and not due to the DMSO
solvent, as shown in Figure 1B, panel d. These results
demonstrate that two well-known inducers of CD4CD8
DP thymocyte death, anti-CD3ε mAb and glucocorticoids,
are blocked by inhibition of cysteine protease activity.
zVADfmk protects DP thymocytes from
Fig. 2. A caspase inhibitor blocks peptide/MHC induced deletion ofantigen-induced deletion in N15 TCR tg RAG-2–/–
DP thymocytes. FACS analysis of FTOC from N15 TCRtg RAG-2–/–
H-2b mice
H-2b mice following 18 h treatment with: (a) no addition; (b) 10 μM
Given that negative selection of thymocytes in vivo is anti- VSV8 peptide; (c) 2 h with 100 μM zVADfmk followed by 18 h with
gen-driven,wenext tested theeffectof zVADfmkonspecific 10 μM VSV8; (d) 2 h with 100 μM zVADmk followed by 18 h with
10 μM VSV8; (e) 2 h with 0.25% DMSO followed by 18 h withpeptide-induced deletion of DP thymocytes in FTOC
10 μM VSV8; (f ) 18 h with 10 μM SEV9. Fetal lobes (five perderived from TCR tg mice. To this end, we employed the
group) were cultured 4 days, treated as indicated and harvested on
N15 TCR tg mouse which bears a class I MHC-restricted day 5. Lobes were dissociated and stained with directly conjugated
TCR and recognizes the vesicular stomatitis virus nuclear anti-CD8-Red613 and anti-CD4-PE. 10 000 cells were analyzed per
dot plot. The numbers within the quadrants represent the percent ofprotein octapeptide VSV8 in the context of H-2 Kb
cells in that quadrant.(Y.Ghendler, R.E.Hussey, T.Witte, E.Mizoguchi, L.K.
Clayton, A.K.Bhan, S.Koyasu, H.-C.Chang and E.L.
Reinherz, manuscript submitted). The VSV8 peptide inter- amount of the unrelated SEV9 Sendai virus-derived pep-
tide, which binds to Kb with a comparable affinity withacts with Kb with high affinity such that a single in vitro
or in vivo exposure efficiently loads the Kb molecules in that of VSV8 but which is not recognized by the N15
TCR, does not result in thymocyte death (Figure 2, panel f).the thymus of these animals. We additionally constructed
the animals on a RAG-2–/– background (Shinkai et al.,
1992), thereby guaranteeing exclusive expression of this Histological analysis of antigen-induced apoptosis
in FTOC of N15 TCR tg RAG-2–/– H-2b mice:TCR on the surface of T-lineage cells. In these experiments,
fetuses were dissected at day 15.5 since we observed blockade of cell death by zVADfmk
Negative selection results in apoptosis of DP thymocytesthat the development of N15 tg RAG-2–/– animals was
-slightly slower than that of the corresponding wild-type as judged by morphological criteria or induction of DNA
fragmentation as analyzed by gel electrophoresis orC57BL/6 animals.
Figure 2a shows that after 5 additional days of FTOC, TUNEL assay (Murphy et al., 1990; Surh and Sprent,
1994). We confirmed that apoptosis in this TCR tg system60% of N15 TCR tg RAG-2–/– H-2b thymocytes are DP
and 24% are CD8 SP thymocytes. Addition of 10–5 M is induced by the VSV8 peptide in N15 FTOC using a
terminal deoxynucleotidyl transferase (TdT) assay onVSV8 peptide to the N15 FTOCs 18 h before analysis
results in massive depletion of CD4CD8 DP thymocytes histological sections as demonstrated in Figure 4. This
method exploits the fact that apoptosis results in DNAwith a reduction from 60% to 2% (Figure 2b). zVADfmk
completely blocks this antigen-induced depletion (Figure cleavage, the ends of which serve as a substrate for the
TdT enzyme, allowing cells undergoing death to be labeled2c). Importantly, zVADmk, a compound identical to
zVADfmk (Figure 3) except for the absence of the fluoride with biotinylated dUTP. Sections were prepared from fetal
thymic lobes cultured as described above and treated foratom which is required for the irreversible inhibition of
caspases, has no effect on the antigen-induced depletion 4 h with 10–5 M VSV8 peptide with either no pretreatment
or a 1 h pretreatment with zVADfmk or zVADmk. Thisof DP thymocytes as shown in Figure 2d. Hence, inhibition
of enzymatic function is a prerequisite for protecting DP early time point was chosen for the characterization as
we had previously observed that, after overnight exposurethymocytes from depletion by specific antigen. Exposure
of the FTOC to the DMSO solvent before VSV8 treatment to VSV8, dying DP thymocytes from adult animals were
already removed by an efficient process involving the non-has no effect (Figure 2e). Figure 2 also shows that the
depletion of DP thymocytes is specifically induced by the lymphoid stromal components of the thymus (Y.Ghendler,
R.E.Hussey, T.Witte, E.Mizoguchi, L.K.Clayton, A.K.VSV8 peptide: addition to the FTOC of an equivalent
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TCR-triggered activation of caspase(s):
a biochemical analysis
Although the above results clearly demonstrate that the
zVADfmk cysteine protease inhibitor can block antigen-
triggered cell death, it remained to be determined whether
TCR ligation specifically activates a cysteine protease.
Members of the caspase family exist as proenzymes which
are cleaved by an activation step to give rise to ~20 kDa
and ~12 kDa subunits (reviewed in Henkart, 1996). The
heterodimeric subunits then associate to form a tetramer.
Because the tetramer—but not the inactive proenzyme—
binds the substrate, we developed a biochemical assay to
examine the state of caspases in thymuses of unstimulated
or in vivo-VSV8-triggered N15 tg mice. To this end,
we tested several possible substrates including biotin–
YVADamk and biotin–DEVDamk (Figure 3). Because the
biotin–DEVDamk substrate appears to have the highest
affinity for the thymic caspase, only these data will be
presented. The significance of this substrate selectivity
will be discussed below.
N15 transgenic RAG-2–/– H-2b mice were injected in
the tail vein with PBS, 24 μg VSV8 or control SEV9
peptide and extracts prepared from the thymocytes of
these adult mice 2 h after injection. Lysate equivalent to
2106 thymocytes was incubated with or without 2 μM
biotin–DEVDamk, which binds irreversibly to caspases at
varying rates depending on the specific protease. Sub-
sequently, the treated lysates were analyzed by 12.5%
SDS–PAGE and blotted onto nitrocellulose. The mem-
branes were then incubated with streptavidin horseradish
Fig. 3. Structures of the peptide-based caspase inhibitors and related peroxidase and developed by ECL. A band of ~17 kDa
compounds. The structures of the peptide-based inhibitor analogues
is induced in the 2 h VSV8-treated thymocytes (Figureused in these studies are shown along with their molecular weight as
5a). This band is not found in lysates from thymuses ofverified by mass spectrometry. The trivial names of the compounds are
also given. Note that the cell-permeable inhibitors (zVADfmk and PBS- or SEV9-injected animals, and is not detected
zVADmk) have the P1 aspartate protected as the methyl ester. On the in thymic lysates without prior incubation with biotin–
other hand, the P1 aspartate of the biotinylated peptides has a free acid DEVDamk (Figure 5a). As expected, purified, recombinantat the β position.
Yama/caspase-3 and Mch2α (caspase-6) proteases bind
the biotin–DEVDamk substrate in this assay (Figure 5b).
The above functional studies utilizing zVADfmk and the
biochemical analysis with biotin–DEVDamk collectivelyBhan, S.Koyasu, H.-C.Chang and E.L.Reinherz, manu-
show that cysteine proteases are activated during antigen-script submitted). The effective removal of corpses has
induced negative selection in the thymus. Whether thealso been previously described in both tg and non-tg
same caspase(s) interacts with both of these inhibitorsthymuses (Surh and Sprent, 1994).
remained to be determined. This possibility was tested byAs shown in Figure 4, VSV8 treatment resulted in an
competitive inhibition analysis wherein the above thymic
obvious increase in the number of TdT-positive cells as
lysates were first preincubated with up to 1000-fold
compared with the control culture which was not exposed
molar excess of zVADfmk before addition of the biotin–
to the VSV8 peptide. Pretreatment with zVADfmk before
DEVDamk. If both substrate inhibitors bound to the same
VSV8 addition reduces the number of TdT-positive cells
enzyme, then the non-biotin-labeled zVADfmk would
to that of the control. In contrast, zVADmk-pretreated block the ability of biotin–DEVDamk to bind to the
cultures which were exposed to VSV8 had levels of TdT- activated thymic caspase and hence, eliminate detection
positive cells similar to cultures treated with VSV8 alone. of the ~17 kDa subunit by streptavidin horseradish peroxid-
Table I shows quantitative immunohistological results for ase. Alternatively, if these inhibitors bound to different
three N15 tg RAG-2–/– H-2b FTOC and a littermate enzymes, then there would be no change in the appearance
control non-tg RAG-2–/– FTOC. Thus, the depletion of of the caspase band as detected by biotin–DEVDamk.
DP thymocytes in the N15 TCR tg RAG-2–/– H-2b FTOC Figure 5c shows that, if the thymic lysates are incubated
is blocked specifically with a cysteine protease inhibitor first with zVADfmk at molar concentrations ranging from
and this inhibition correlates with a reduction in the 1000- to 100-fold that of the biotin–DEVDamk substrate,
number of apoptotic cells as determined by TdT assays. the ~17 kDa band is no longer detectable by Western blot
To our knowledge, this is the first demonstration that analysis. In contrast, at lower zVADfmk:biotin–DEVDamk
inhibition of a caspase(s) prevents apoptotic cell death ratios (10:1 or 1:1), the biotin–DEVDamk substrate is
induced by antigen triggering of the TCR on immature bound by the TCR-triggered cysteine protease and there-
fore detected as a ~17 kDa biotinylated inhibitor–enzymeDP thymocytes.
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Fig. 4. Inhibition of caspase activity blocks antigen-induced apoptosis of thymocytes. TUNEL analysis was performed on histological sections of
thymuses from N15 tg RAG–/– H-2b FTOC. Thymuses were: untreated (control); treated with 10 μM VSV8 peptide for 4 h (VSV8); 1 h with
100 μM zVADfmk and 4 h with 10 μM VSV8 peptide (VSV8  zVADfmk); 1 h with 100 μM zVADmk and 4 h with 10 μM VSV8 peptide
(VSV8  zVADmk). A 40 objective was used.
complex. Thus, the irreversible binding of zVADfmk
Table I. Quantitation of cell death in FTOC by TUNEL assay
which blocks VSV8-induced depletion of the DP thymo-
cytes in FTOC competes with the biotin–DEVDamk Treatment TdT-positive cells (mm2)
substrate for binding to the same ~17 kDa band. This
N15tg #1 N15tg #2 N15tg #3 non-tgresult links the antigen-induced negative selection of
thymocytes as measured by depletion of DP thymocytes
Control 7a 28 7 1
in FTOC to the appearance of an activated cysteine VSV8 429 456 441 9
zVADfmk  VSV8 6 1 2 6protease detectable in the thymuses of mice undergoing
zVADmk VSV8 360 525 461 NDnegative selection. Figure 5d shows that, while a 100-fold
molar excess of zVADfmk blocks binding of the biotin–
In the above experiments (n  3) of which these results are
DEVDamk substrate to the antigen-activated cysteine representative, fetuses were offspring of N15 tg/– Rag-2–/– H-2b
protease, the same excess of zVADmk does not block this males and RAG-2–/– H-2b females and derived from the same litters.
aMean number of TdT-positive cells/mm2 in six fields from Figure 4.interaction. This finding is consistent with our observation
ND, not determined.that zVADmk fails to block antigen-induced depletion of
the DP thymocytes in FTOC.
brown), consistent with the large percentage of DP thymo-
cytes present in the thymus of these animals. StainingLocalization of activated caspase to TCR-triggered
cortical thymocytes in N15 tg RAG-2–/– H-2b fetal with biotin–DEVDamk (blue) is negative. In contrast, 4 h
after treatment with VSV8, the CD4 staining has becomeand adult mice
To localize the activated caspase within the thymus of patchy and the morphology of the CD4 cells is altered
with less discrete cell boundaries. In addition, therefetal and adult N15 tg RAG–/– H-2b mice, we performed
two-color immunohistological analysis using biotin– is widespread biotin–DEVDamk staining throughout the
cortex, indicative of antigen-induced activation of a thymicDEVDamk and anti-CD4 mAb. In the N15 RAG–/– H-2b
mice, CD4 staining is essentially limited to the DP caspase. Consistent with the biochemical analysis, this
activation is blocked by pretreatment with zVADfmk butthymocytes because the N15 TCR is class I MHC-
restricted, resulting in positive selection of CD8 SP cells not with zVADmk.
The same staining pattern is evident in adult N15 tgexclusively. In Figure 6A, we show a control FTOC
section stained with biotin–DEVDamk and anti-CD4. The RAG-2–/– H-2b mice as shown in Figure 6B. Thymic
sections of N15 tg RAG-2–/– H-2b animals are positivemajority of thymocytes demonstrate CD4 staining (red/
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thymic caspase. Double staining with anti-CD4 mAb and
biotin–DEVDamk of thymic sections from both fetal and
adult N15 TCRtg RAG-2–/– H-2b mice demonstrates that
the caspase is activated in the DP thymocyte subpopulation
within a time frame of 2 h. Subsequently, at 4 h, we
observed a tremendous increase in the number of apoptotic
thymocytes determined by TUNEL assays of histological
sections of thymuses. At 18 h, by FACS analysis and
immunohistological analysis, 90% of the DP thymocyte
population is deleted. Both the disappearance of DP
thymocytes and the increase in numbers of apoptotic cells
in histological sections are blocked by treatment of FTOC
with zVADfmk, a peptide-based inhibitor of cysteine
proteases.
Biochemical analysis of thymic lysates prepared from
adult N15 TCRtg RAG-2–/– H-2b mice using a biotinylated
substrate of cysteine proteases, biotin–DEVDamk, con-
firms the induction of an active caspase within 2 h after
tail vein injection of VSV8 antigen. This enzyme activation
is specifically induced as it is not activated in control
(PBS) or irrelevant peptide (SEV9) -treated animals.
Pretreatment of the thymic lysates with an excess of the
irreversible inhibitor zVADfmk prevents binding of the
biotin–DEVDamk to the caspase while the chemically
related control compound zVADmk does not. zVADmk
also has no effect on antigen-induced depletion of DP
thymocytes in FTOC or the appearance of TUNEL-
Fig. 5. Western blot analysis reveals antigen-induced activation of a positive cells in histological sections upon VSV8 peptide
thymic caspase. (A) Thymic extracts prepared from PBS, VSV8 or treatment of FTOC. Thus, the zVADfmk which blocks
SEV9 injected N15 tg RAG-2–/– H-2b mice were incubated 15 min
depletion of DP thymocytes in FTOC also blocks bindingwith () or without (–) 2 μM biotin-DEVDamk, run on 12.5% SDS–
of the biotin–DEVDamk to its substrate. We conclude thatPAGE under non-reducing conditions and blotted onto nitrocellulose.
The membrane was incubated with horseradish peroxidase-conjugated the caspase functionally inhibited by zVADfmk in FTOC
streptavidin and developed by ECL. Each lane contained thymic is the same as that detected by biotin–DEVDamk by
extract equivalent to 2106 thymocytes. VSV8 peptide injections were
Western blot analysis. Activation of this caspase is theperformed 1.5 h before. (B) 140 ng of purified, recombinant Mch2α
molecular basis for negative selection of DP thymocytes.and 3.5 ng of purified, recombinant Yama were incubated 15 min with
2 μM biotin–DEVDamk and analyzed as described in (a). (C) Thymic Our interpretation of the above data is that the TCR of
extracts prepared from mice 2 h after VSV8 peptide injection were the double-positive thymocyte binds the peptide/MHC on
incubated 15 min with 2 μM biotin–DEVDamk alone, 2 μM an antigen-presenting stromal cell with the restricted
zVADfmk alone, or preincubated 15 min with an excess of 1000,
association of the CD4 or CD8 co-receptor; in the case500, 100, 10 or an equal concentration of zVADfmk relative to
of the N15 TCR transgenic mouse, the CD8 co-receptorbiotin–DEVDamk. Biotin–DEVDamk was then added to 2 μM and the
incubation continued for 15 min. Lysates were then run on 12.5% is involved. If the affinity of the TCR/peptide/MHC
SDS–PAGE and analyzed as described in (a). (D) Thymic extracts interaction is of sufficient magnitude, as is true for
isolated from mice 2 h after VSV8 peptide injection were incubated
the N15 TCR and VSV8/Kb complex, the thymocyte is15 min with 2 μM biotin–DEVDamk alone (–), or, alternatively,
triggered to undergo negative selection. Upon this trigger-incubated 15 min with 200 μM zVADfmk or zVADmk and then
biotin–DEVDamk added to 2 μM for another 15 min. Lysates were ing, a procaspase is cleaved to form an active tetramer
then analyzed as described in (a). Arrows indicate the position of the which catabolizes yet to be identified cellular substrates,
activated thymic caspase subunit which binds the biotin–DEVDamk. resulting in apoptosis of the DP thymocyte. It is reasonable
to assume that a similar mechanism is operative via B-cell
for anti-CD4 reactivity and negative for that of biotin–
receptors in early B-cell development.
DEVDamk. However, 4 h following tail vein injection of
What is the identity of the activated thymic caspase?
VSV8 peptide, the thymic section demonstrates wide-
Analysis of the Western blots demonstrates that there is
spread biotin–DEVDamk staining and the same alterations
likely only one enzyme activated given that there is a
in anti-CD4 reactivity as seen in the VSV8-treated FTOCs.
single predominant band by gel analysis. The less intense
PBS injection does not induce damage to the CD4
band migrating slightly faster than the major band may
thymocytes or detectable activation of the cysteine pro-
be a degradation product or post-translational modification.
tease. Thus, deletion of DP thymocytes occurs through
We cannot exclude the possibility, however, that a secondantigen-stimulated activation of a cysteine protease in
caspase might be activated. If the latter is the case, thenboth FTOC and adult mice, and this activity localizes to
both enzymes must be blocked by the zVADfmk inhibitor.the thymocytes themselves.
Studies to date defining substrates and inhibitors of known
caspases offer additional insights into the possible identity
Discussion
of the thymic caspase. Peptide-based inhibitors serve to
characterize different substrate specificities among theWe have demonstrated that peptide/MHC-induced negative
selection of DP thymocytes involves the activation of a caspase family members. The tetrapeptide aldehyde Ac-
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Fig. 6. Histological analysis of thymic caspase expression in fetal and adult thymuses. (A) Sections of thymic lobes were obtained from control N15
TCR tg RAG-2–/– H-2b FTOC or FTOC treated for 4 h with 10 μM VSV8 peptide, 1 h with 100 μM zVADfmk followed by 4 h with 10 μM VSV8
peptide or 1 h with 100 μM zVADmk followed by 4 h with 10 μM VSV8 peptide and then double-stained with anti-CD4 mAb (red/brown) and
biotin–DEVDamk (blue). (B) Histological analysis of thymic sections from adult N15 TCRtg RAG-2–/– H-2b animals uninjected (control) or injected
4 h previously with 24 μg VSV8 peptide or PBS. Sections were double-stained with biotin–DEVDamk and anti-CD4 as in (A). A 25 objective
was used.
YVAD-CHO inhibits caspase-1 at ~10 000-fold lower Studies with proteins which inhibit their functional
enzymatic activity further serve to categorize the caspaseconcentration than that required to inhibit caspase-3. In
contrast, Ac-DEVD-CHO inhibits caspase-3 activity 49- family members. Bcl-2, first identified as a proto-oncogene
in B-cell follicular lymphomas, inhibits some forms offold better than caspase-1 (Rotonda et al., 1996). Utilizing
thymic lysates from VSV8-injected N15 TCRtg RAG–/– apoptotic cell death including death induced by ICH-1
(caspase-2) (reviewed in Yang and Korsmeyer, 1996). TheH-2b mice, biotin–YVADamk failed to detect the caspase
readily revealed by biotin–DEVDamk. The recombinant cytokine response modifier, crmA, derived from the cowpox
virus inhibits caspase-1 but not caspase-2. At high concen-caspase-3 protein used as a positive control was detected
by biotin–YVADamk only when 100-fold more of the trations, however, crmA also inhibits caspase-3 (Nicholson
et al., 1995; Tewari et al., 1995). Negative selection isenzyme was used (data not shown). The crystal co-
complex structures of caspase-1 and -3 and their inhibitors unaffected in Bcl-2 (Sentman et al., 1991) and caspase-1
(Kuida et al., 1995; Li et al., 1995) knockout animals. Theclarify the observed substrate specificities (Walker et al.,
1994; Wilson et al., 1994; Rotonda et al., 1996): the S4 recent crmA transgenic mouse in which crmA is directed to
the T-cell compartment via a CD2 enhancer demonstrates asubsite in caspase-1 is a hydrophobic depression into
which a tyrosine residue fits nicely as in the ac-YVAD- phenotype in which CD95-induced peripheral T-cell
apoptosis is inhibited, but negative selection in the thymusCHO peptide aldehyde inhibitor. In contrast, the compar-
able S4 subsite in caspase-3 forms a narrow pocket fitting appears to be unaffected (Smith et al., 1996). The inhibitors
Bcl-2 and crmA have complementary effects in that thetightly around an aspartic acid residue as in the ac-DEVD-
CHO peptide aldehyde inhibitor. This substrate difference crmA transgene does not affect γ-irradiation or dexametha-
sone-induced apoptosis, while Bcl-2 does just the oppositesuggests that the thymic caspase should be grouped
with the caspase-3-like cysteine proteases rather than the and inhibits both. Neither Bcl-2 nor crmA transgenes, how-
ever, affect negative selection. Thus, while negative selec-caspase-1-like group.
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tion appears to proceed via an apoptotic pathway, the peptide/MHC, since there are two CD3ε molecules per
TCR and only one binding site for peptide/MHC. Further-components of this process are undefined. One would expect
that the thymic caspase described here would not be more, the mAb is bivalent, unlike the peptide/MHC
which is monovalent. The most likely explanation for thisinhibited by crmA or by Bcl-2.
Analysis of apoptotic pathways triggered by different apparent paradox is that peptide/MHC-induced triggering
may recruit other molecules which synergize to provide astimuli in cells transfected with Bcl-2 and crmA have
been used to suggest molecular ordering of particular more potent death signal than that exclusively provided
by crosslinking of TCR molecules by mAb. Furthermore,caspases within death pathways and further imply the
presence of a cascade of caspases with one member other signaling molecules have been shown to affect
negative selection as discussed below, although their rolesactivating others. Studies suggest a molecular ordering in
which Bcl-2 and Bcl-xL, a homologue of Bcl-2, function in activation of the caspase remain to be determined.
Certainly, there is precedent for the role of dual signalingupstream of caspase-3, -6 and -7 (Chinnaiyan et al., 1996c;
Orth et al., 1996a); crmA also appears to function by within the T-cell lineage: activation of resting peripheral
T-cells requires TCR crosslinking as well as co-stimulationinhibiting a protease upstream of caspase-3, -6 and -7 but
in a different pathway from that inhibited by Bcl-2 through CD28 and its ligands, B7-1 and B7-2 (reviewed in
Bluestone, 1995). Apoptosis of peripheral T-cells involves(Chinnaiyan et al., 1996c; Orth et al., 1996a).
Granzyme B is a serine protease which cleaves at an second signals through Fas (CD95) and Fas–ligand, the
expression of which are regulated by TCR signalingaspartic acid in its substrate (Murphy et al., 1988; Odake
et al., 1991; Vaux et al., 1992; Caputo et al., 1994) and (Crispe, 1994). Such dual signaling may also play a role
in thymic selection; a second signal derived from thymicis activated only in cytolytic T-lymphocytes (Hanson and
Ley, 1990; Hanson et al., 1991; Heusel et al., 1991). Post- stroma along with the specificity-determining TCR/pep-
tide/MHC interaction may be required for negative selec-activation, granzyme B is transferred into target cells
where it initiates caspase cleavage, notably of caspase 3 tion (Page et al., 1993; Degermann et al., 1994; Punt
et al., 1994; Lerner, et al., 1996). Targeted disruption of(Darmon et al., 1995; Quan et al., 1996). Thus, proteases
other than caspases may activate these enzymes initiating CD30, another member of the TNF receptor family,
produces a phenotype suggestive of a defect in negativethe cascade of caspase functional programs leading to cell
death. ICH-3 has also been shown to be activated by selection (Amakawa et al., 1996). Thus, receptor–ligand
interactions between thymocytes and stromal cells maygranzyme B (Wang et al., 1996). Ordering of ICH-3
activity places it upstream of caspase-1 in the granzyme induce a second signal(s) from the stroma which is
important in the modulation of negative selection.B pathway and also upstream of caspase-3.
Certain cysteine proteases have been analyzed by tar- Glucocorticoids induce deletion of DP thymocytes in
FTOC of C57BL/6 mice and this deletion is blocked bygeted gene disruption. Caspase-1 knockout animals do not
have a generalized death defect, suggesting that this zVADfmk. Rat and mouse thymocytes in suspension also
undergo glucocorticoid-induced death which is blockedenzyme may not be central to all death pathways (Kuida
et al., 1995; Li et al., 1995). The CD95-induced death by zVADfmk (Fearnhead et al., 1995; Sarin et al., 1996).
This death pathway is inhibited by Bcl-2, in contrast topathway is affected in these animals, but negative selection
is not altered in lpr mice bearing the spontaneous CD95 that of negative selection (reviewed in Yang and
Korsmeyer, 1996). Since both forms of DP thymocytemutation (reviewed by Rozzo et al., 1994). Furthermore,
we have not observed cleavage of poly(ADP-ribose) depletion are blocked by zVADfmk while Bcl-2 selectively
affects glucocorticoid-induced deletion but does not alterpolymerase (PARP) in thymic lysates of C57BL/6 animals
injected intraperitoneally with anti-CD3ε mAb (data not negative selection, it appears that the glucocorticoid and
antigen/MHC pathways share some—but not all—com-shown). Since PARP is a substrate of caspase-3, this
suggests that caspase-3 is also not responsible for the ponents of the death pathway. In addition, it has recently
been shown that zVADfmk also blocks in vitro apoptoticobserved thymic apoptosis. Assuming that the crmA
levels were sufficiently high in the crmA transgenic mice death in mouse thymocytes triggered by etoposide, radi-
ation, anti-Fas and anti-CD3 (Sarin et al., 1996). It thusdescribed above (Smith et al., 1996), then caspase-3 would
have been inhibited in those mice, and yet negative appears that a number of independent agents trigger death
pathways which may converge to a common death effectorselection was unaffected. The absence of an effect on
thymopoiesis in caspase-3 knockout mice is also consistent mechanism involving a thymic caspase.
It is a long-standing enigma as to how events whichwith this notion (Kuida et al., 1996). These studies suggest
that the thymic caspase is not caspase-1 or caspase-3; induce negative selection and death in immature thymo-
cytes induce activation and accompanying proliferation inhowever, the possibility remains that these molecules are
involved in the process of negative selection but that mature T-cells (Kappler et al., 1987; Ramarli et al., 1987).
Hence, the developmental stage of the T-cell determinesredundancy with other proteases obscures a phenotype in
knockout animals. its response to a particular stimulus. In TCR transgenic
mice, antigenic peptides which activate peripheral T-cellsThe anti-CD3ε mAb-induced deletion of DP thymocytes
was also blocked by zVADfmk in FTOC, suggesting that to proliferate trigger depletion of the immature thymocytes
bearing the identical TCR (Fowlkes and Pardoll, 1989).the same caspase involved in peptide/MHC-triggered death
is active in this apoptotic pathway. However, crosslinking Most TCR transgenic models in which deletion by peptide
antigen has been examined demonstrate that the deletionwith this antibody did not induce deletion of DP thymo-
cytes to the same extent as did peptide/MHC (Figures 1a involves the immature DP thymocytes (Murphy et al.,
1990; Vasquez et al., 1992; Ashton-Rickardt et al., 1994;and 2). One might expect that crosslinking with anti-CD3ε
mAb would be more extensive than that induced by Hogquist et al., 1994; Sebzda et al., 1994). The presence
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Grand Island, NY). Harvested thymocytes were washed and stained forof the peptide/MHC-activated caspase in the DP thymocyte
30 min with anti-CD4 and anti-CD8 mAbs. Flow cytometric analysissubset further identifies this population as the one in which
was performed on a FACScan (Becton Dickinson, San Jose, CA).
negative selection is operative. Samples were gated on live cells based on forward and side scatter
Recently, using N15 TCRtg RAG-2–/– H-2b mice, we parameters. Data on 10 000 events per sample were collected in list
mode using FACScan Research software and analyzed using LYSYSIIidentified a population of DP TCRhigh thymocytes which
software (Becton Dickinson).is resistant to deletion by peptide antigen (Y.Ghendler,
R.E.Hussey, T.Witte, E.Mizoguchi, L.K.Clayton, A.K.
Synthesis of peptide-based inhibitors and related
Bhan, S.Koyasu, H.-C.Chang and E.L.Reinherz, manu- compounds
script submitted). Presumably, these thymocytes have N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone, β-methyl ester
(zVADfmk) was from Enzyme System Products (Dublin, CA). Biotin–already been positively selected by an endogenous peptide
YVADamk was purchased from Amersham Life Science (Arlingtonantigen (APL) before VSV8 injection and are on their
Heights, IL).
way to becoming mature CD8 SP T-cells. By what basis N-[biotinylaspartyl(β-t-butyl ester)]glutamyl(γ-t-butyl ester)valine was
are they resistant to negative selection? If the activation prepared by solid phase synthesis on a 2-chlorotrityl resin (Barlos et al.,
of a caspase is the mechanism by which negative selection 1991) using an HOAt/HATU coupling protocol (Carpino et al., 1994).
Acyloxyketone, N-Z-aspartic acid[(2,6-dimethylbenzoyl)oxy]-methyloperates, then these cells must be unable to activate the
ketone, β-t-butyl ester, was prepared according to the method of Krantzthymic caspase upon TCR engagement with VSV8. It
et al. (1991) from the corresponding bromomethyl ketone (Dolle et al.,
may be that the caspase mRNA is expressed only at a 1994a) and deprotected by hydrogenolysis (Dolle et al., 1994b) to afford
limited stage of development and these cells no longer aspartic acid[(2,6-dimethylbenzoyl)oxy]methyl ketone, β-t-butyl ester,
as the HCl salt. Coupling of this amine with N-[biotinylaspartyl(β-t-express the caspase gene. The fact that zVADfmk and
butyl ester)glutamyl](γ-t-butyl ester)valine was carried out by HOAt/the related compound Boc-Asp(OMe)-fluoromethylketone
HATU-mediated solution phase synthesis (Carpino, 1993) as follows.
have different blocking effects when tested in mouse
N-(biotinylaspartylglutamylvalinyl)aspartic acid [(2,6-dimethylbenzoyl)-thymocytes versus mouse T-cell blasts (Sarin et al., 1996)
oxy]methyl ketone (biotin–DEVDamk). To an ice-cooled solution
supports the notion that death pathways in T-cells at of N-[biotinylaspartyl(β-t-butyl ester)glutamyl](γ-t-butyl ester)valine
different stages of development may use different caspase (150 mg, 0.215 mmol), aspartic acid[(2,6-dimethylbenzoyl)oxy]methyl
ketone, β-t-butyl ester hydrochloride (80 mg, 0.215 mmol), HOAtfamily members when death is triggered by the same
(30 mg, 0.215 mmol) and HATU (125 mg, 0.33 mmol) in DMF (1 ml)input pathway. Alternatively, the DP TCRhigh thymocytes
was added diisopropylethyl amine (110 μl, 0.645 mmol) and the resultingmay produce an inhibitor of the thymic caspase such as
solution was allowed to warm to room temperature. After stirring
a Bcl-2-like molecule which inactivates the thymic cas- overnight, the mixture was concentrated under reduced pressure, and the
pase. In addition, a molecule which provides a second residue was chromatographed on a silica gel column eluting with
chloroform followed by chloroform:methanol (20:1). The material wassignal(s) necessary for thymic selection as discussed above
further purified by a second silica gel column eluting with chloroformmay no longer be expressed on the DP TCRhigh thymocytes.
followed by a gradient of chloroform:acetone:methanol (4:1:0)–(2:1:0)–
Once the genetic and biochemical details of the negative (2:1:1%) to afford 60 mg of the coupled product as a colorless solid.
selection pathway are defined, it should be possible to The tert-butyl esters were removed by treating this material with a
mixture of TFA:DCM (3:2, 2.5 ml) at room temperature for 3 h.determine which of these mechanisms accounts for the
Concentration under reduced pressure followed by repeated treatmentescape of the DP TCRhigh thymocytes from peptide/MHC-
(3) with toluene (0.5 ml) and concentration afforded 50 mg of theinduced death.
desired product as a light-yellow solid. Recrystallization from methanol
gave a pure product which was shown by reverse-phase HPLC (C18)
analysis to consist of a 1:1 mixture of diastereoisomers. Similar to theMaterials and methods
observation of Thornberry et al. (1994), 1H NMR analysis indicated the
Animals diastereomeric center to be at the P1 aspartic acid α-carbon. ES mass
All animals were maintained at the animal facility of Dana-Farber Cancer spectrum (M–) m/e 847 [M-H], 869 [M-HNa]; ES mass spectrum
Institute. N15 TCR tg RAG-2–/– H-2b animals were constructed as (M) m/e 849 [MH], 871 [MNa].
previously described (Y.Ghendler, R.E.Hussey, T.Witte, E.Mizoguchi, N-(Z-valinylalanyl)aspartic acid methyl ketone, β-methyl ester
L.K.Clayton, A.K.Bhan, S.Koyasu, H.-C.Chang and E.L.Reinherz, manu- (z-VADmk). This was prepared as a diastereomeric mixture (racemic at
script submitted). These animals express α and β TCR chains isolated aspartyl α-carbon) from N-(Z-valinylalanyl)aspartic acid, β-methyl ester
from the N15 CTL clone (Chang et al., 1994). The constructs were (standard solid phase coupling) by a Dakin-West reaction with acetic
engineered using TCR shuttle vectors kindly provided by M.Davis anhydride, triethylamine and DMAP at 50°C (Steglich and Hofle, 1969).
(Patten et al., 1993). N15 tg lines were maintained and bred under sterile FAB mass spectrum (M) m/e 450 [MH].
barrier standard conditions. C57BL/6 mice were purchased from Taconic.
For injection of 145-2C11, the anti-CD3ε mAb was purified by standard
Immunohistological analysis and TUNEL assay
procedures (Coligan et al., 1994) and 200 μg injected intraperitoneally
Fetal thymuses were embedded in O.C.T. compound (Miles, Elkhart,
in PBS. For injection of peptide, 24 μg of VSV8 (RGYVYQGL) or
IN) on dry ice. 4 μm sections were prepared and subsequently stored
SEV9 (FAPGNYPAL) was injected in 100 μl PBS into the tail vein
at –80°C. Immunohistochemical studies were performed as previously
of mice.
described (Mombaerts et al., 1993). For the TUNEL assay, frozen tissue
sections were fixed in 3% buffered formalin for 10 min at roomFTOC
temperature. After washing with PBS, sections were fixed again inFetuses of C57BL/6 mice were dissected at day 14.5 of pregnancy, with
ethanol:acetic acid (2:1) for 10 min at –20°C. Endogenous peroxidasethe day of the vaginal plug counted as day 1. Fetuses of N15 TCRtg
activity was blocked by covering the sections with 0.5% H2O2 for 20RAG-2–/– H-2b mice were dissected at day 15.5. Fetal lobes were
min at room temperature. The sections were rinsed with PBS andremoved and cultured in 6-well Transwell dishes (Costar, Kennebunk,
immersed in TdT buffer (30 mM Trizma base, pH 7.2, 140 mM sodiumME) using 1.6 ml of complete DMEM-10 as described by Coligan et al.
cacodylate, 1 mM cobalt chloride). The sections were incubated with 2–(1994). The samples were incubated in a humidified atmosphere with
4 mM biotinylated dUTP (Boehringer-Mannheim, Germany) and 10 U5% CO2 for 4–5 days at 37°C and treated with specific reagents as
TdT (Promega, Madison, WI) in 25 μl TdT buffer in a humid atmospheredescribed in the text. For harvesting, lobes were ground between frosted
at 37°C for 2 h. The reaction was terminated by transferring the slidesglass slides in PBS–1% BSA, washed and used for FACS analysis.
to TB buffer (300 mM NaCl, 30 mM Na citrate) for 15 min. After a
PBS rinse, sections were incubated with 2% BSA for 10 min, rinsed inFlow cytometric analysis
Monoclonal antibodies used were R-phycoerythrin (PE) labeled anti- PBS for 5 min, incubated with avidin–biotinylated peroxidase complex
(Dako, Santa Barbara, CA) diluted 1:100 in PBS for 30 min, washed inCD4 (H129.19) and Red613 labeled anti-CD8 (53-6.7) (Gibco-BRL,
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PBS and developed with 3-amino-9-ethylcarbazole (Aldrich, Milwaukee, chloride resin: studies on anchoring of Fmoc-amino acids and peptide
cleavage. Int. J. Pept. Protein Res., 37, 513–520.WI). Sections were lightly counterstained with Meyer’s hematoxin
(Gavrieli et al., 1992). Becker,M.L.B., Near,R., Mudgett-Hunter,M., Margolies,M.N., Kubo,
R.T., Kaye,J. and Hedrick,S.M. (1989) Expression of a hybridTwo-color immunohistochemical analysis was performed as previously
described (Mizoguchi et al., 1996). Briefly, 4-μm thick specimens were immunoglobulin T cell receptor protein in transgenic mice. Cell, 58,
911–921.fixed in acetone for 7 min, air-dried, and incubated with purified anti-
CD4 antibody (clone L3T4, PharMingen, San Diego, CA) for 1 h at Bluestone,J.A. (1995) New Perspectives of CD28-B7-mediated T cell
costimulation. Immunity, 2, 555–559.room temperature. Specimens were incubated for 30 min with 0.3%
H2O2 in PBS to block endogenous peroxidase activity. Endogenous Caputo,A., James,M.N.G., Powers,J.C., Hudig,D. and Bleackley,R.C.
(1994) Conversion of the substrate specificity of mouse proteinasebiotin was blocked by sequential incubations with avidin-D (Vector,
Burlingame, CA) and d-biotin (Sigma, St Louis, MO). For detection, granzyme B. Nature Struct. Biol., 1, 364–367.
Carpino,L.A. (1993) 1-Hydroxy-7-azabenzotriazole: an efficient peptidebiotinylated rabbit anti-rat Ig (Vector) was used, followed by an optimal
dilution of avidin-biotinylated–peroxidase complex (Dako). The speci- coupling additive. J. Am. Chem. Soc., 115, 4397–4398.
Carpino,L.A., El-Faham,A., Minor,C.A. and Albericio,F. (1994)mens were developed in a solution of 3-amino-9-ethylcarbazole (Aldrich)
and the reaction stopped by dipping in distilled water for 5 min and Advantageous applications of azabenzotriazole (triazolopyridine)-
based coupling reagents to solid phase peptide synthesis. J. Chem.washing in PBS, pH 7.4, for 10 min. The specimens were then incubated
with biotin–DEVDamk peptide at room temperature for 1 h, followed Soc. Chem. Commun., 201–203.
Chang, H-C. et al. (1994) A general method for facilitating heterodimericby incubation with ABC-alkaline phosphatase reagent (Vector) for
30 min. After 15 min development with alkaline phosphatase substrate pairing between two proteins: application to expression of α and β T
cell receptor extracellular segments. Proc. Natl Acad. Sci. USA, 91,Kit III (Vector) and 1 mM levamisole (Sigma), the specimens were post-
fixed with 2% paraformaldehyde and mounted with glycergel (Dako). 11408–11412.
Chapman,K.T. (1992) Synthesis of a potent, reversible inhibitor of
interleukin-1β converting enzyme. Bioorg. Med. Chem. Lett., 2,Preparation of thymic lysates and Western blot analysis
613–618.Thymocyte suspensions were prepared as described above for FACS.
Chinnaiyan,A.M., O’Rourke,K., Yu,G-L., Lyons,R.H., Garg,M.,Cells were washed three times in PBS–1% BSA and lysates prepared
Duan,D.R., Xing,L., Gentz,R., Ni,J. and Dixit,V.M. (1996a) Signalas previously described (Thornberry et al., 1994). Briefly, thymocytes
transduction by DR3, a death domain-containing receptor related towere resuspended at 1108/ml in hypotonic buffer containing 25 mM
TNFR-1 and CD95. Science, 274, 990–992.HEPES, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 1 mM PMSF, 10 μg/ml
Chinnaiyan,A.M., Tepper,C.G., Seldin,M.F., O’Rourke,K., Kishkel,F.C.,leupeptin and 10 μg/ml pepstatin. After 20 min on ice, cells were broken
Hellbardt,S., Krammer,P.H., Peter,M.E. and Dixit,V.M. (1996b) FADD/with 20 strokes in a tight-fitting Dounce homogenizer. Cell lysates were
MORT1 is a common mediator of CD95 (Fas/APO-1) and tumorclarified by centrifugation at 2000 r.p.m. in an Eppendorf microfuge for
necrosis factor receptor-induced apoptosis. J. Biol. Chem., 271,10 min followed by an 8 min spin in a Beckman airfuge at 100 000 g.
4961–4965.The lysates were dialyzed overnight at 4°C against 20 mM Tris, pH 7.8,
Chinnaiyan,A.M., Orth,K., O’Rourke,K., Duan,H., Poirier,G.G. and2 mM DTT and 0.1% CHAPS. Cell lysates were aliquoted and stored
Dixit,V.M. (1996c) Molecular ordering of the cell death pathway:at –80°C. Recombinant Yama and Mch2α were prepared as described
Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic(Orth et al., 1996b).
proteases. J. Biol. Chem., 271, 4373–4576.For Western blot analysis, cell lysate equivalent to 2106 cells was
Coligan,J.E., Kruisbeek,A.M., Margulies,D.H., Shevach,E.M. andincubated with the indicated additions for 15 min at 25°C. Non-reducing
Strober,W. (1994) Current Protocols in Immunology. John Wiley &sample buffer was added, samples boiled for 7 min and run on 12.5%
Sons, New York.SDS–PAGE under non-reducing conditions. Gels were blotted onto
Crispe,I.N. (1994) Fatal interactions: Fas-induced apoptosis of immaturenitrocellulose and the membranes blocked overnight in PBS, 3% BSA,
T cells. Immunity, 1, 347–349.0.1% Tween-20. The filter was washed twice for 10 min in PBS, 0.1%
Darmon,A.J., Nicholson,D.W. and Bleackley,R.C. (1995) Activation ofBSA, 0.1% Tween-20 and incubated 2 h at room temperature with a
the apoptotic protease CPP-32 by cytotoxic T cell-derived granzyme1:10 000 dilution of streptavidin-conjugated horseradish peroxidase
B. Nature, 377, 446–448.(ICN, Costa Mesa, CA) in PBS, 0.1% BSA, 0.1% Tween-20. The filter
Degermann,S., Surh,C.D., Glimcher,L.H., Sprent,J. and Lo,D. (1994) B7was washed 610 min with 50 mM Tris–HCl, pH 7.5, 0.25% gelatin,
expression on thymic medullary epithelium correlates with epithelium-0.05% Tween-20, 150 mM NaCl, 5 mM EDTA, then washed once in
mediated deletion of Vβ5 thymocytes. J. Immunol., 152, 3254–3263.PBS and developed by ECL (Renaissance, NEN, Boston, MA).
Dolle,R.E., Hoyer,D., Prasad,C.V., Schmidt,S.J., Helaszek,C.T.,
Miller,R.E. and Ator,M.A. (1994a) P1 aspartate-based peptide α-
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